Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-18 5:25 pm Sale | 2023-12-14 | 13D | Seagen Inc. SGEN | Baker Bros. Advisors LP | 0 0.000% | -45,074,469 (Position Closed) | Filing History |
| 2023-06-09 3:48 pm Sale | 2023-06-12 | 13G | Seagen Inc. SGEN | Capital International Investors | 7,227,865 3.900% | -10,830,216 (-59.97%) | Filing History |
| 2023-05-03 4:15 pm Purchase | 2023-05-01 | 13D | Seagen Inc. SGEN | Baker Bros. Advisors LP | 45,074,469 24.000% | 45,074,469 (New Position) | Filing History |
| 2023-03-13 4:30 pm Purchase | 2023-03-12 | 13D | Seagen Inc. SGEN | Baker Bros. Advisors LP | 47,233,651 25.300% | 10,043 (+0.02%) | Filing History |
| 2023-02-13 3:54 pm Purchase | 2023-02-14 | 13G | Seagen Inc. SGEN | Capital International Investors | 18,058,081 9.700% | 5,279,652 (+41.32%) | Filing History |
| 2023-02-10 4:20 pm Unchanged | 2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Seagen Inc. SGEN | 46,327 5.000% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Seagen Inc. SGEN | VANGUARD GROUP INC | 12,945,078 6.970% | 805,039 (+6.63%) | Filing History |
| 2023-02-06 2:58 pm Sale | 2022-12-30 | 13G | Seagen Inc. SGEN | Wellington Management Group LLP | 9,881,292 5.320% | -1,748,437 (-15.03%) | Filing History |
| 2023-01-31 5:52 pm Sale | 2022-12-31 | 13G | Seagen Inc. SGEN | BlackRock Inc. BLK | 11,861,464 6.400% | -1,480,289 (-11.10%) | Filing History |
| 2022-03-10 4:40 pm Sale | 2022-03-08 | 13D | Seagen Inc. SGEN | Baker Bros. Advisors LP | 47,223,608 25.700% | -394,895 (-0.83%) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Seagen Inc. SGEN | Capital International Investors | 12,778,429 7.000% | -7,094,465 (-35.70%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Seagen Inc. SGEN | VANGUARD GROUP INC | 12,140,039 6.640% | 254,756 (+2.14%) | Filing History |
| 2022-02-04 09:22 am Purchase | 2021-12-31 | 13G | Seagen Inc. SGEN | Wellington Management Group LLP | 11,629,729 6.360% | 11,629,729 (New Position) | Filing History |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | Seagen Inc. SGEN | BlackRock Inc. BLK | 13,341,753 7.300% | 821,674 (+6.56%) | Filing History |
| 2021-05-18 4:41 pm Purchase | 2021-05-14 | 13D | Seagen Inc. SGEN | Baker Bros. Advisors LP | 47,618,503 26.200% | 3,226 (+0.01%) | Filing History |
| 2021-04-02 4:20 pm Purchase | 2021-03-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Seagen Inc. SGEN | 46,327 6.200% | 46,327 (New Position) | Filing History |
| 2021-02-16 4:04 pm Unchanged | 2021-02-16 | 13G | Seagen Inc. SGEN | Capital International Investors | 19,872,894 11.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 2:24 pm Purchase | 2021-02-16 | 13G | Seagen Inc. SGEN | Capital International Investors | 19,872,894 11.000% | 19,872,894 (New Position) | Filing History |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Seagen Inc. SGEN | T. Rowe Price Associates, Inc. | 7,526,240 4.100% | 7,526,240 (New Position) | Filing History |
| 2021-02-10 11:52 am Purchase | 2020-12-31 | 13G | Seagen Inc. SGEN | VANGUARD GROUP INC | 11,885,283 6.590% | 11,885,283 (New Position) | Filing History |